Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity DOI Creative Commons
Mahboubeh Hosseini-Kharat, Kristen E. Bremmell, Branka Grubor‐Bauk

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 378, С. 170 - 194

Опубликована: Дек. 12, 2024

DNA-based therapies are often limited by challenges such as stability, long-term integration, low transfection efficiency, and insufficient targeted DNA delivery. This review focuses on recent progress in the design of non-viral delivery systems for enhancing modulation therapeutic efficiency. Cellular uptake intracellular trafficking mechanisms play a crucial role optimizing gene There two main strategies employed to improve efficiency vectors: (i) explore different administration routes (e.g., mucosal, intravenous, intramuscular, subcutaneous, intradermal, intratumoural, intraocular) that best facilitates optimal into cells organs (ii) modify vectors with cell-specific ligands natural ligands, antibodies, peptides, carbohydrates, or aptamers) enable specific higher specificity improved biodistribution. We describe how employing these is advancing field increasing clinical translation ultimate application therapies.

Язык: Английский

Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics DOI Creative Commons
Oana Elena Nicolaescu,

Ionela Belu,

Andreea Gabriela Mocanu

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 288 - 288

Опубликована: Фев. 22, 2025

Cyclodextrins (CDs) have revolutionized the pharmaceutical industry with their ability to enhance stability, solubility, and bioavailability of a wide range active substances. These cyclic oligosaccharides, unique hydrophilic exterior hydrophobic cavity, form inclusion complexes poorly soluble drugs, improving pharmacokinetic profiles therapeutic efficacy. This review explores multifaceted roles cyclodextrins in formulations, ranging from oral, ophthalmic, parenteral, topical applications emerging use targeted therapies, gene delivery, treatment neurodegenerative, cardiovascular, infectious diseases. not only improve drug solubility controlled release but also reduce toxicity side effects, leading safer more effective treatments. Recent advancements, such as cyclodextrin-based nanoparticles, offer promising pathways for cancer therapy, chronic disease management, personalized medicine. As research continues, remain at forefront innovation delivery systems, ensuring better patient outcomes expanding possibilities modern therapeutics.

Язык: Английский

Процитировано

4

Chemical and physical characterization, stability and antioxidant activity of avicularin/(2-hydroxypropyl)-β-cyclodextrin inclusion complex DOI
Xiaoai Zhu, Yong Cao,

Qianchun Deng

и другие.

Food Bioscience, Год журнала: 2025, Номер unknown, С. 106201 - 106201

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Research Trends in the Development of Block Copolymer-Based Biosensing Platforms DOI Creative Commons
Yong-Ho Chung, Jung Kwon Oh

Biosensors, Год журнала: 2024, Номер 14(11), С. 542 - 542

Опубликована: Ноя. 8, 2024

Biosensing technology, which aims to measure and control the signals of biological substances, has recently been developed rapidly due increasing concerns about health environment. Top–down technologies have used mainly with a focus on reducing size biomaterials nano-level. However, bottom–up such as self-assembly can provide more opportunities molecular-level arrangements directionality shape biomaterials. In particular, block copolymers (BCPs) their significantly explored an effective means achieve recent advances in fine imaging technology. BCPs widely various biosensing research fields because they artificially highly complex nano-scale structures directionally controlled manner, future application based interactions biomolecules according development synthesis new BCP is greatly anticipated. Here, we comprehensively discuss basic principles current status applications limitations prospects. Rather than discussing specific field depth, this study covers overall content platform, through this, hope increase researchers’ understanding adjacent inspiration, thereby bringing great relevant fields.

Язык: Английский

Процитировано

2

Cyclodextrin-transition metal complexes emerge as promising tools for modulating peptide function DOI

Dnyaneshwari Domb,

Pravin Shende

Journal of Molecular Liquids, Год журнала: 2024, Номер unknown, С. 126621 - 126621

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

1

PEO-b-PCL/Tween 80/cyclodextrin systems: from bioinspired fabrication to possible nasal administration of ropinirole hydrochloride DOI Creative Commons
Elmina-Marina Saitani, Νatassa Pippa, Diego Romano Perinelli

и другие.

Journal of Materials Chemistry B, Год журнала: 2024, Номер 12(27), С. 6587 - 6604

Опубликована: Янв. 1, 2024

Hybrid PEO- b -PCL/Tween 80/cyclodextrin systems: physicochemical and morphological characterization, in vitro release studies.

Язык: Английский

Процитировано

0

Surface spin engineering of InBiSe3 enabled self-powered polarization-sensitive photodetector DOI

Jing Deng,

Yunqing Tang, Bin Liu

и другие.

Applied Surface Science, Год журнала: 2024, Номер unknown, С. 162024 - 162024

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

0

Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity DOI Creative Commons
Mahboubeh Hosseini-Kharat, Kristen E. Bremmell, Branka Grubor‐Bauk

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 378, С. 170 - 194

Опубликована: Дек. 12, 2024

DNA-based therapies are often limited by challenges such as stability, long-term integration, low transfection efficiency, and insufficient targeted DNA delivery. This review focuses on recent progress in the design of non-viral delivery systems for enhancing modulation therapeutic efficiency. Cellular uptake intracellular trafficking mechanisms play a crucial role optimizing gene There two main strategies employed to improve efficiency vectors: (i) explore different administration routes (e.g., mucosal, intravenous, intramuscular, subcutaneous, intradermal, intratumoural, intraocular) that best facilitates optimal into cells organs (ii) modify vectors with cell-specific ligands natural ligands, antibodies, peptides, carbohydrates, or aptamers) enable specific higher specificity improved biodistribution. We describe how employing these is advancing field increasing clinical translation ultimate application therapies.

Язык: Английский

Процитировано

0